Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
On March 22, a donation of N-95 masks arrived at Columbia University Irving Medical Center (CUIMC) donated by Tesla, the American electric vehicle and clean energy company.
The explosion of COVID-19 cases in China was largely driven by people with mild or no symptoms who went undetected, according to a new study from Columbia University Mailman School of Public Health.
The National Institutes of Health has provided the Center for Infection and Immunity live SARS-CoV-2 samples to use in research to develop rapid tests and identify sources of transmission.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.
Researchers hoped treatment of HIV-infected infants within hours of birth would increase remission, but a new study finds that starting treatment within the first two weeks leads to similar outcomes.
Op-ed for CNN by Dr. Edith Bracho-Sanchez, a primary care pediatrician and Assistant Professor of Pediatrics at Columbia University Irving Medical Center.
Columbia's David Ho and Wafaa El-Sadr—who have been fighting HIV and AIDS since the beginning of the epidemic in the 1980s—say ending AIDs in the United States by 2030 will take political will.